LIXTE BIOTECHNOLOGY HOLDINGS, INC. Shares Outstanding

Quick Answer

LIXTE BIOTECHNOLOGY HOLDINGS, INC. reported Shares Outstanding of 8.79 million shares for fiscal year 2025.

LIXTE BIOTECHNOLOGY HOLDINGS, INC. Shares Outstanding — Annual History

Fiscal Year Shares Outstanding YoY Change
2025 8.79M +290.8%
2024 2.25M +0.0%
2023 2.25M +35.1%
2022 1.66M -87.9%
2021 13.75M +10.8%
2020 12.40M +11.0%
2019 11.17M -83.3%
2018 67.05M +15.5%
2017 58.03M +21.2%
2016 47.88M +0.0%
2015 47.88M +5.3%
2014 45.48M +9.4%
2013 41.58M +0.0%
2012 41.58M +17.9%
2011 35.26M +0.5%
2010 35.08M +40.3%
2006 25.00M

Quarterly Shares Outstanding

Quarter Ending Shares Outstanding YoY QoQ
September 30, 2025 5.70M +153.6% +106.9%
June 30, 2025 2.76M +22.6% +2.7%
March 31, 2025 2.68M +19.3% +19.3%
December 31, 2024 2.25M +0.0% +0.0%
September 30, 2024 2.25M +0.0% +0.0%
June 30, 2024 2.25M +35.0% +0.0%
March 31, 2024 2.25M -86.5% +0.0%
December 31, 2023 2.25M +35.1% +0.0%
  • LIXTE BIOTECHNOLOGY HOLDINGS, INC. showed an increase of +290.8% in Shares Outstanding compared to the prior fiscal year.
  • Over the 2006–2025 period, LIXTE BIOTECHNOLOGY HOLDINGS, INC.’s shares outstanding has declined by 64.8% (from 25.00 million shares to 8.79 million shares).
  • The most recent figure is from LIXTE BIOTECHNOLOGY HOLDINGS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment